Skip to main content
SpringerLink
Log in

Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro

  • Original Contributions
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Summary

The hyperproliferative human keratinocyte line (HaCaT) was tested for dithranol tolerance (tachyphylaxis) at the cellular level. At day 4 after seeding, keratinocytes were treated with 0.3 or 1.0 ΜM dithranol. Data were compared with those from experiments including additional pretreatments with 0.3 ΜM at day 3, or at days 1 and 3. Protein content, DNA synthesis and protein synthesis (incorporation of 3H-thymidine and 14C-amino acids per protein) were determined at 24, 48 and 72 h after the last drug exposure. Protein content of attached cells decreased in relation to dose and frequency of treatments. Inhibition of DNA and protein synthesis (38.2% and 32.3%, respectively) also occurred 24 h after a single treatment with 0.3 ΜM dithranol, but was only 18.4% and 9.1% after pretreatment twice with 0.3 ΜM dithranol. This tolerance reaction in vitro, after repeated dithranol exposure of human keratinocytes, may be explained by a selective loss of drug-sensitive cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ashton RE, Andre P, Lowe NJ, Whitefield M (1983) Anthralin: historical and current perspectives. J Am Acad Dermatol 9:173–192

    Google Scholar 

  2. Bedord CJ, Young JM, Wagner BM (1983) Anthralin inhibition of mouse epidermal arachidonic acid lipoxygenase in vitro. J Invest Dermatol 81:566–571

    Google Scholar 

  3. Bonnekoh B, Wevers A, Jugert F, Merk H, Mahrle G (1989) Colorimetric growth assay for epidermal cell cultures by their crystal violet binding capacity. Arch Dermatol Res 281:487–490

    Google Scholar 

  4. Bonnekoh B, Farkas B, Geisel J, Mahrle G (1990) Lactate dehydrogenase release as an indicator for dithranol induced membrane injury in cultured human keratinocytes — A time profile study. Arch Dermatol Res 282:325–329

    Google Scholar 

  5. Bonnekoh B, Tanzer H, Seidel M, Geisel J, Merk HF, Wiegrebe W, Mahrle G (1991) Structural — functional relationship of new anthralin derivatives assayed for growth inhibition and cytotoxicity in human keratinocyte cultures. Arch Pharm (Weinheim) (in press)

  6. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761–771

    Google Scholar 

  7. Brandt H, Mustakallio KK (1983) Irritation and staining by dithranol (anthralin) and related compounds. III. Cumulative irritancy and staining during repeated chamber testing. Acta Derm Venereol (Stockh) 63:237–240

    Google Scholar 

  8. Brown WR, Rogozinski TT, Ramsey CA (1988) Anthralin and tar with UVB increase epidermal cell proliferation in asebia mice. Clin Exp Dermatol 13:248–251

    Google Scholar 

  9. Brown WR, Furukawa RD, Ramsay CA (1989) UVB radiation further stimulates proliferation in the already hyperproliferative epidermis of the asebia mouse. Arch Dermatol Res 281:366–367

    Google Scholar 

  10. Cavey D, Caron JC, Shroot B (1981) Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition. Br J Dermatol 105 [Suppl 20]:15–19

    Google Scholar 

  11. Clark JM, Hanawalt PC (1982) Inhibition of DNA replication and repair by anthralin or danthron in cultured human cells. J Invest Dermatol 79:18–22

    Google Scholar 

  12. De Mare S, Calis N, Hartog G den, Erp PEJ van, Kerkhof PCM van de (1988) The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol 1:259–264

    Google Scholar 

  13. De Mare S, Calis N, Hartog G den, Kerkhof PCM van de (1989) Outpatient treatment with short-contact dithranol. The impact of frequent concentration adjustments. Acta Derm Venereol (Stockh) 69:449–451

    Google Scholar 

  14. Duvall E, Wyllie AH (1986) Death and the cell. Immunol Today 7:115–119

    Google Scholar 

  15. Du Vivier A (1976) Tachyphylaxis to topically applied steroids. Arch Dermatol 112:1245–1248

    Google Scholar 

  16. Du Vivier A, Stoughton RB (1975) Tachyphylaxis to the action of topically applied corticosteroids. Arch Dermatol 111:581–583

    Google Scholar 

  17. Fuchs J (1988) Validity of the “bioassay” for thioredoxin-reductase activity. Arch Dermatol 124:849–850

    Google Scholar 

  18. Fuchs J, Packer L (1989) Investigation of anthralin free radicals in model systems and in skin of hairless mice. J Invest Dermatol 92:677–682

    Google Scholar 

  19. Fuchs J, Zimmer G, Wölbling RH, Milbradt R (1986) On the interaction between anthralin and mitochondria: a revision. Arch Dermatol Res 279:59–65

    Google Scholar 

  20. Galewsky (1916) über Cignolin, ein ErsatzprÄparat des Chrysarobins. Dermatol Wochenschr 6:113–115

    Google Scholar 

  21. Kanerva L (1990) Electron microscopy of the effects of dithranol on healthy and on psoriatic skin. Am J Dermatopathol 12:51–62

    Google Scholar 

  22. Kemeny L, Ruzicka T, Braun-Falco O (1990) Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol 3:1–20

    Google Scholar 

  23. Klem EB (1978) Effect of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in culture. J Invest Dermatol 70:27–32

    Google Scholar 

  24. Lawrence CM, Shuster S (1985) Mechanism of anthralin inflammation. 2. Effect of pretreatment with glucocorticoids, anthralin and removal of stratum corneum. Br J Dermatol 113:117–122

    Google Scholar 

  25. Lotti T, Brunetti L, Panconesi E (1986) A ‘novel’ action of anthralin. Arch Dermatol 122:748–749

    Google Scholar 

  26. Luthman M, Holmgren A (1982) Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 21:6628–6633

    Google Scholar 

  27. Mann HB, Whitney DR (1947) On a test of whether one of two random variables is stochastically larger than the other. Ann Math Statist 18:50–60

    Google Scholar 

  28. Morliére P, Dubertret L, Sa E Melo T, Salet C, Fosse M, Santus R (1985) The effect of anthralin (dithranol) on mitochondria. Br J Dermatol 112:509–515

    Google Scholar 

  29. Müller K, Wiegrebe W, Younes M (1987) Dithranol, active oxygen species and lipid peroxidation in vivo. Arch Pharm (Weinheim) 320:59–66

    Google Scholar 

  30. Plumier E, Wappes B, Wiegrebe W (1984) Incorporation of 3H-thymidine into DNA: inhibition of dithranol and its di- and triacetate. Arch Dermatol Res 276:406–408

    Google Scholar 

  31. Prunieras M, Delescluse C (1984) Epidermal cell culture systems in skin pharmacology. Br J Dermatol 27:43–47

    Google Scholar 

  32. Pullmann H, Enderer K, Steigleder GK (1981) Cytokinetic effects of anthralin on psoriatic keratinocytes. Br J Dermatol 105 [Suppl 20]:55–56

    Google Scholar 

  33. Reichert U (1986) Skin toxicity and cellular metabolism: in vitro models. Br J Dermatol 115 [Suppl 31]:108–116

    Google Scholar 

  34. Reichert U, Jacques Y, Grangeret M, Schmidt R (1985) Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytes. J Invest Dermatol 84:130–134

    Google Scholar 

  35. Retzow A, Plumier E, Wiegrebe W (1981) Untersuchungen zur Hemmung der Glukose-6-Phosphat-Dehydrogenase durch Dithranol. Pharm Zeitg 126:2150–2155

    Google Scholar 

  36. Schaefer H, Schalla W, Shroot B (1981) Anthralip-facts, trends and unresolved problems. Zentralbl Haut Geschlechtskrankh 146:273–282

    Google Scholar 

  37. Schallreuter KU, Pittelkow MR (1987) Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis — A new mode of action for this drug. Arch Dermatol 123:1494–1498

    Google Scholar 

  38. Schallreuter KU, Wood JM (1989) Free radical reduction in the human epidermis. Free Radic Biol Med 6:519–532

    Google Scholar 

  39. Schulze HJ, Schauder S, Mahrle G, Steigleder GK (1987) Combined tar-anthralin versus anthralin treatment lowers irritancy with unchanged antipsoriatic efficacy. J Am Acad Dermatol 17:19–24

    Google Scholar 

  40. Shroot B, Schalla W, Schaefer H (1985) Anthralin. In: Roenigk HH, Maibach HI (eds) Psoriasis. Marcel Dekker, New York Basel, p 329

    Google Scholar 

  41. Steigleder GK, Schumann H, Lennartz KJ (1973) Autoradiographic in vitro examination of psoriatic skin before, during and after dithranol treatment. Arch Dermatol Forsch 246:231–235

    Google Scholar 

  42. Tucker WFG, MacNeil S, Dawson RA, Tomlinson S, Bleehen SS (1986) An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin). J Invest Dermatol 87:232–235

    Google Scholar 

  43. Yoshino K, Maibach HI (1985) Kinetics of epidermal DNA synthesis in hairless mice after multiple anthralin application. J Invest Dermatol 84:325

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Cologne, UniversitÄts-Hautklinik, Joseph-Stelzmann-Strasse 9, W-5000, Köln 41, Federal Republic of Germany

    B. Farkas, B. Bonnekoh & G. Mahrle

Authors
  1. B. Farkas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Bonnekoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Mahrle
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This study was supported in part by the W.-Doerenkamp-Foundation. B. F. from the Department of Dermatology, Albert Szent-Györgyi Medical University of Szeged, Hungary, is a fellow of the Alexander-von-Humboldt-Foundation. On the occasion of the 65th birthday of Prof. Dr. Dr. h. c. G. K. Steigleder

Rights and permissions

Reprints and permissions

About this article

Cite this article

Farkas, B., Bonnekoh, B. & Mahrle, G. Repeated treatment with dithranol induces a tolerance reaction in keratinocytes in vitro. Arch Dermatol Res 283, 337–341 (1991). https://doi.org/10.1007/BF00376624

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00376624

Key words

Search

Navigation